This study hypothesized that APS might inhibit miR-200b-3p by reducing SP1 level, and activate Wnt/β-catenin signaling to improve SONFH, which may supply important insights into SONFH treatment. Here, SP1 is linked to autoimmune polyendocrinopathy.